Cerity Partners LLC Purchases 41,847 Shares of Select Medical Holdings Co. (NYSE:SEM)

Cerity Partners LLC grew its position in Select Medical Holdings Co. (NYSE:SEM) by 67.0% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 104,281 shares of the health services provider’s stock after acquiring an additional 41,847 shares during the period. Cerity Partners LLC owned about 0.08% of Select Medical worth $2,033,000 at the end of the most recent quarter.

Several other institutional investors also recently modified their holdings of the company. Envestnet Asset Management Inc. increased its position in Select Medical by 6.3% during the fourth quarter. Envestnet Asset Management Inc. now owns 366,033 shares of the health services provider’s stock worth $6,900,000 after buying an additional 21,771 shares during the last quarter. Integrated Quantitative Investments LLC bought a new stake in Select Medical in the 4th quarter valued at $292,000. Foundry Partners LLC lifted its holdings in Select Medical by 6.0% during the 4th quarter. Foundry Partners LLC now owns 260,729 shares of the health services provider’s stock valued at $4,915,000 after purchasing an additional 14,869 shares during the last quarter. Kesler Norman & Wride LLC boosted its position in Select Medical by 114.4% during the fourth quarter. Kesler Norman & Wride LLC now owns 24,233 shares of the health services provider’s stock worth $457,000 after purchasing an additional 12,930 shares during the period. Finally, Trexquant Investment LP raised its position in shares of Select Medical by 29.4% in the fourth quarter. Trexquant Investment LP now owns 145,113 shares of the health services provider’s stock valued at $2,735,000 after purchasing an additional 32,936 shares during the period. 89.48% of the stock is currently owned by institutional investors and hedge funds.

Select Medical Price Performance

Shares of NYSE SEM opened at $16.33 on Thursday. The stock has a market capitalization of $2.11 billion, a PE ratio of 9.90, a P/E/G ratio of 0.64 and a beta of 1.38. Select Medical Holdings Co. has a fifty-two week low of $14.99 and a fifty-two week high of $40.98. The company has a debt-to-equity ratio of 1.37, a current ratio of 1.13 and a quick ratio of 1.13. The business has a fifty day moving average price of $17.37 and a two-hundred day moving average price of $23.23.

Select Medical (NYSE:SEM) last posted its quarterly earnings data on Thursday, February 20th. The health services provider reported $0.18 earnings per share for the quarter, missing the consensus estimate of $0.29 by ($0.11). Select Medical had a return on equity of 14.04% and a net margin of 3.23%. The firm had revenue of $1.31 billion for the quarter, compared to the consensus estimate of $1.50 billion. As a group, equities analysts predict that Select Medical Holdings Co. will post 1.17 earnings per share for the current fiscal year.

Select Medical Cuts Dividend

The company also recently disclosed a quarterly dividend, which was paid on Thursday, March 13th. Shareholders of record on Monday, March 3rd were given a dividend of $0.0625 per share. The ex-dividend date of this dividend was Monday, March 3rd. This represents a $0.25 annualized dividend and a yield of 1.53%. Select Medical’s dividend payout ratio is currently 15.15%.

Analyst Ratings Changes

SEM has been the topic of a number of research reports. Mizuho began coverage on shares of Select Medical in a research note on Wednesday. They issued an “outperform” rating and a $25.00 price target on the stock. Royal Bank of Canada decreased their target price on Select Medical from $47.00 to $23.00 and set an “outperform” rating on the stock in a research report on Monday, February 24th. UBS Group dropped their price target on Select Medical from $40.00 to $21.00 and set a “neutral” rating for the company in a report on Friday, January 3rd. StockNews.com upgraded Select Medical from a “hold” rating to a “buy” rating in a research report on Friday, February 21st. Finally, Benchmark raised shares of Select Medical from a “hold” rating to a “buy” rating and set a $23.00 target price for the company in a research report on Monday, February 24th. One investment analyst has rated the stock with a hold rating and five have given a buy rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $26.80.

Select Medical Company Profile

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.